Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zegocractin by CalciMedica for Pancreatitis: Likelihood of Approval
Zegocractin is under clinical development by CalciMedica and currently in Phase II for Pancreatitis. According to GlobalData, Phase II drugs...